Agilon Health (AGL) Competitors $1.06 -0.02 (-1.39%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$1.08 +0.01 (+0.94%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AGL vs. PGNY, ARDT, NHC, AVAH, PACS, NAKA, VRDN, OMDA, TDOC, and GRALShould you be buying Agilon Health stock or one of its competitors? The main competitors of Agilon Health include Progyny (PGNY), Ardent Health (ARDT), National HealthCare (NHC), Aveanna Healthcare (AVAH), PACS Group (PACS), KindlyMD (NAKA), Viridian Therapeutics (VRDN), Omada Health (OMDA), Teladoc Health (TDOC), and GRAIL (GRAL). These companies are all part of the "healthcare" industry. Agilon Health vs. Its Competitors Progyny Ardent Health National HealthCare Aveanna Healthcare PACS Group KindlyMD Viridian Therapeutics Omada Health Teladoc Health GRAIL Progyny (NASDAQ:PGNY) and Agilon Health (NYSE:AGL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment. Do analysts recommend PGNY or AGL? Progyny presently has a consensus price target of $25.30, suggesting a potential upside of 12.39%. Agilon Health has a consensus price target of $3.07, suggesting a potential upside of 188.40%. Given Agilon Health's higher possible upside, analysts plainly believe Agilon Health is more favorable than Progyny.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Progyny 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.73Agilon Health 2 Sell rating(s) 12 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.11 Which has stronger valuation & earnings, PGNY or AGL? Progyny has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProgyny$1.24B1.56$54.34M$0.5938.15Agilon Health$6.06B0.07-$260.15M-$0.77-1.38 Do institutionals and insiders have more ownership in PGNY or AGL? 94.9% of Progyny shares are held by institutional investors. 9.4% of Progyny shares are held by insiders. Comparatively, 3.6% of Agilon Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is PGNY or AGL more profitable? Progyny has a net margin of 4.28% compared to Agilon Health's net margin of -5.35%. Progyny's return on equity of 10.69% beat Agilon Health's return on equity.Company Net Margins Return on Equity Return on Assets Progyny4.28% 10.69% 7.12% Agilon Health -5.35%-66.76%-17.47% Does the media favor PGNY or AGL? In the previous week, Progyny had 4 more articles in the media than Agilon Health. MarketBeat recorded 12 mentions for Progyny and 8 mentions for Agilon Health. Progyny's average media sentiment score of 1.35 beat Agilon Health's score of 0.65 indicating that Progyny is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Progyny 9 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Agilon Health 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, PGNY or AGL? Progyny has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Comparatively, Agilon Health has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. SummaryProgyny beats Agilon Health on 15 of the 17 factors compared between the two stocks. Get Agilon Health News Delivered to You Automatically Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGL vs. The Competition Export to ExcelMetricAgilon HealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$447.58M$7.66B$5.87B$21.65BDividend YieldN/A2.77%5.68%3.48%P/E Ratio-1.3874.0174.5229.75Price / Sales0.0742.19517.4468.29Price / CashN/A24.1437.5625.00Price / Book0.937.3512.164.58Net Income-$260.15M$238.91M$3.28B$1.00B7 Day Performance-10.88%2.63%0.87%0.65%1 Month Performance2.40%1.47%4.96%3.07%1 Year Performance-69.79%16.57%60.75%14.34% Agilon Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGLAgilon Health2.8748 of 5 stars$1.07-1.4%$3.07+188.4%-67.9%$447.58M$6.06B-1.381,076PGNYProgyny3.7502 of 5 stars$22.85+1.3%$25.30+10.7%-3.2%$1.94B$1.17B41.00310Positive NewsARDTArdent Health3.6153 of 5 stars$13.45+2.2%$19.56+45.4%-27.4%$1.88B$5.97B7.2724,900News CoveragePositive NewsAnalyst ForecastNHCNational HealthCareN/A$115.93+0.9%N/A-6.9%$1.80B$1.46B14.5312,400AVAHAveanna Healthcare1.469 of 5 stars$8.26+0.5%$7.50-9.2%+61.4%$1.72B$2.02B31.6133,500Short Interest ↑PACSPACS Group3.0644 of 5 stars$11.29+1.0%$33.33+195.4%-75.5%$1.70B$3.11B0.0032,433Trending NewsNAKAKindlyMD2.4552 of 5 stars$4.56+11.8%$8.00+75.4%N/A$1.53B$2.72M0.00N/ANews CoverageOptions VolumeGap DownHigh Trading VolumeVRDNViridian Therapeutics2.2362 of 5 stars$19.81+5.8%$37.78+90.7%-8.8%$1.53B$300K0.0050Positive NewsOMDAOmada HealthN/A$24.03-1.0%$24.50+2.0%N/A$1.40BN/A0.00849TDOCTeladoc Health2.843 of 5 stars$7.84+0.2%$9.80+25.0%+1.0%$1.38B$2.57B0.005,500Positive NewsGRALGRAIL0.6595 of 5 stars$38.23+3.6%$31.50-17.6%+180.7%$1.33B$125.60M0.001,360Positive News Related Companies and Tools Related Companies Progyny Alternatives Ardent Health Alternatives National HealthCare Alternatives Aveanna Healthcare Alternatives PACS Group Alternatives KindlyMD Alternatives Viridian Therapeutics Alternatives Omada Health Alternatives Teladoc Health Alternatives GRAIL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AGL) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agilon Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agilon Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AGL Stock Alerts